Status:
NOT_YET_RECRUITING
Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?
Lead Sponsor:
Baylor Research Institute
Collaborating Sponsors:
Baylor Scott and White Health
Conditions:
Pediatric Disorder
Eligibility:
All Genders
3-18 years
Phase:
PHASE4
Brief Summary
To examine the difference in pain control in the pediatric general surgery population alternating acetaminophen and Ibuprofen q 3 hours vs giving them simultaneous combination therapy around the clock...
Detailed Description
The purpose of the study is to compare the difference in pain control in the pediatric general surgery population of those who receive alternating acetaminophen and ibuprofen every 3 hours to those wh...
Eligibility Criteria
Inclusion
- Age group: 3 years to 18 years
- General surgery service (hernia, appendectomy, chole, circumcision, wounds, vacs, implanted central line, etc.)
Exclusion
- Patients who are allergic to acetaminophen and/or ibuprofen
- Patients being evaluated by SANE or evaluated for nonaccidental trauma
- Patients admitted post-op
- The study will take place at McLane Children's Hospital Temple Market. Patients who are pregnant.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06505148
Start Date
August 1 2024
End Date
August 1 2025
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott & White Health Temple Market
Temple, Texas, United States, 76508